We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

97 hedge funds and large institutions have $310M invested in Pernix Therapeutics Holdings, Inc. in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

160% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 10

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

54% more capital invested

Capital invested by funds: $202M → $310M (+$109M)

17% more funds holding

Funds holding: 8397 (+14)

66% less call options, than puts

Call options by funds: $819K | Put options by funds: $2.38M

Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
2.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.16%
New
26
Increased
37
Reduced
23
Closed
10
Calls
$819K
Puts
$2.38M
Net Calls
-$1.56M
Net Calls Change
-$540K
Name Holding Trade Value Shares
Change
Change in
Stake
JHIU
1
Janus Henderson Investors US
Colorado
$34M +$316K +3,310 +0.9%
CCM
2
Consonance Capital Management
New York
$32.2M -$146K -1,535 -0.4%
BC
3
Broadfin Capital
New York
$28.6M -$4.29M -45,000 -13%
AC
4
Aisling Capital
New York
$18.9M
KCM
5
Kennedy Capital Management
Missouri
$15.3M +$9.39M +98,470 +152%
BFA
6
BlackRock Fund Advisors
California
$13M +$5.6M +58,748 +74%
WSA
7
Wall Street Associates
California
$11.8M +$933K +9,780 +8%
ACA
8
Avoro Capital Advisors
New York
$10.7M +$10.8M +113,458 New
O
9
OrbiMed
New York
$10.1M
BIT
10
BlackRock Institutional Trust
California
$9.13M +$261K +2,736 +3%
Bank of Montreal
11
Bank of Montreal
Ontario, Canada
$8.12M -$4.54M -47,613 -36%
CAM
12
Cortina Asset Management
Wisconsin
$7.88M +$8M +83,903 New
KIA
13
Kopp Investment Advisors
Minnesota
$7.12M -$348K -3,643 -5%
CM
14
Castleark Management
Illinois
$6.79M +$6.89M +72,271 New
Vanguard Group
15
Vanguard Group
Pennsylvania
$6.51M +$634K +6,645 +11%
CPIM
16
Columbia Partners Investment Management
Virginia
$6.42M +$6.52M +68,376 New
ACP
17
Acuta Capital Partners
California
$5.67M +$5.76M +60,408 New
Allianz Asset Management
18
Allianz Asset Management
Germany
$5.13M -$57.8K -606 -1%
EI
19
EAM Investors
California
$4.71M +$1.73M +18,161 +57%
ECP
20
Elk Creek Partners
Colorado
$4.46M +$1.75M +18,378 +63%
AP
21
Alydar Partners
Massachusetts
$3.85M +$3.91M +41,000 New
State Street
22
State Street
Massachusetts
$3.78M +$1.3M +13,621 +51%
Wells Fargo
23
Wells Fargo
California
$3.54M +$3.58M +37,539 +24,535%
JAM
24
Jupiter Asset Management
United Kingdom
$3.37M -$1.86M -19,540 -35%
Northern Trust
25
Northern Trust
Illinois
$3.19M -$131K -1,378 -4%

PTX Hedge Fund Activity: Q4 2014 in Review

97 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2014, worth a combined $310M — up 54% from $202M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PTX positions and 10 closed out — a net gain of 16 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $9.39M. The largest seller was Bank of Montreal, cutting an estimated $4.54M.

  • 97 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2014, up from 83 in Q3 2014.
  • Funds reported $310M of Pernix Therapeutics Holdings, Inc. stock for Q4 2014, up 54% quarter-over-quarter.
  • 26 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2014 and 10 closed out, a net change of +16 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2014 was Kennedy Capital Management, an estimated $9.39M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2014 was Bank of Montreal, an estimated $4.54M sold.

Based on aggregated 13F filings for Q4 2014.